Gilder Gagnon Howe & Co’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-71,761	Closed	-$2.82M	–	320
2023 Q2	$2.82M	Sell	71,761 -196	-0.3%	-$6.92K	0.04%	179
2023 Q1	$1.75M	Sell	71,957 -335	-0.5%	-$7.33K	0.03%	179
2022 Q4	$1.55M	Sell	72,292 -33	-0%	-$704	0.03%	183
2022 Q3	$1.3M	Sell	72,325 -24,843	-26%	-$326K	0.02%	189
2022 Q2	$935K	Sell	97,168 -85,175	-47%	-$1.07M	0.02%	201
2022 Q1	$3.07M	Sell	182,343 -2,214	-1%	-$32.7K	0.03%	204
2021 Q4	$3.09M	Buy	+184,557	New	+$3.02M	0.02%	249
2016 Q4	–	Sell	-1,411	Closed	-$65K	–	292
2016 Q3	$65K	Sell	1,411 -92	-6%	-$5.19K	﹤0.01%	254
2016 Q2	$77K	Buy	+1,503	New	+$74.7K	﹤0.01%	256

Gilder Gagnon Howe & Co's ISEE Position: Q3 2023 in Review

Gilder Gagnon Howe & Co sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 71,761 shares — an estimated $2.82M sold.

Gilder Gagnon Howe & Co first reported a position in ISEE in Q2 2016 and held it in 9 quarters. The position peaked at $3.09M in Q4 2021. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

Gilder Gagnon Howe & Co reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Gilder Gagnon Howe & Co sold 71,761 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $2.82M.
Gilder Gagnon Howe & Co first reported a position in IVERIC bio, Inc. Common Stock in Q2 2016 and held it in 9 quarters.
Gilder Gagnon Howe & Co's IVERIC bio, Inc. Common Stock position peaked at $3.09M in Q4 2021.
0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Gilder Gagnon Howe & Co's 13F filing for Q3 2023, filed 14 Nov 2023.